These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28092348)

  • 21. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
    Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
    Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective Study of Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Leukemia: 25 Years' Experience at Gustave Roussy Cancer Campus.
    Chamseddine AN; Willekens C; De Botton S; Bourhis JH
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S129-40. PubMed ID: 26297265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Outcomes of haplotype allogeneic hematopoietic stem cell transplantation in 17 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia].
    Zhou J; Zhou H; Zhang R; Wu D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):170-2. PubMed ID: 24606664
    [No Abstract]   [Full Text] [Related]  

  • 24. Should anyone with Philadelphia chromosome-positive ALL who is negative for minimal residual disease receive a hematopoietic stem cell transplant in first remission?
    Litzow MR
    Best Pract Res Clin Haematol; 2016 Dec; 29(4):345-350. PubMed ID: 27890258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
    Takeuchi J
    Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
    Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
    Hwang YY; Mohty M; Chim CS
    Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Cui JK; Xiao Y; You Y; Shi W; Li Q; Luo Y; Jiang L; Zhong ZD
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):693-698. PubMed ID: 29058281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.
    Gao L; Zhang C; Gao L; Liu Y; Su Y; Wang S; Li B; Yang T; Yuan Z; Zhang X
    J Hematol Oncol; 2015 Jul; 8():90. PubMed ID: 26208715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.
    Yanada M; Takeuchi J; Sugiura I; Akiyama H; Usui N; Yagasaki F; Nishii K; Ueda Y; Takeuchi M; Miyawaki S; Maruta A; Narimatsu H; Miyazaki Y; Ohtake S; Jinnai I; Matsuo K; Naoe T; Ohno R;
    Haematologica; 2008 Feb; 93(2):287-90. PubMed ID: 18223280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic cell transplantation for acute lymphoblastic leukemia in adult patients.
    El Fakih R; Ahmed S; Alfraih F; Hanbali A
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):252-258. PubMed ID: 28644949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402.
    Azuma T; Tobinai K; Takeyama K; Shibata T; Hidaka M; Kurosawa M; Kasai M; Chou T; Fukushima N; Mukai K; Tsukasaki K; Shimoyama M;
    Jpn J Clin Oncol; 2012 May; 42(5):394-404. PubMed ID: 22422899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal evolution detected with conventional cytogenetic analysis is a potent prognostic factor in adult patients with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Shimizu H; Yokohama A; Ishizaki T; Hatsumi N; Takada S; Saitoh T; Sakura T; Handa H
    Leuk Res; 2021 Apr; 103():106535. PubMed ID: 33611095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic hematopoietic cell transplantation for adult Philadelphia-positive acute lymphoblastic leukemia in the era of tyrosine kinase inhibitors.
    Abou Mourad YR; Fernandez HF; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):949-958. PubMed ID: 18721758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005.
    Rives S; Estella J; Gómez P; López-Duarte M; de Miguel PG; Verdeguer A; Moreno MJ; Vivanco JL; Couselo JM; Fernández-Delgado R; Maldonado M; Tasso M; López-Ibor B; Lendínez F; López-Almaraz R; Uriz J; Melo M; Fernández-Teijeiro A; Rodríguez I; Badell I
    Br J Haematol; 2011 Sep; 154(5):600-11. PubMed ID: 21707583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of outcomes following autologous stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia during first complete remission.
    Kato H; Kawase T; Kako S; Mizuta S; Kurokawa M; Mori T; Ohashi K; Iwato K; Miyamura K; Hidaka M; Sakamaki H; Suzuki R; Morishima Y; Tanaka J;
    Haematologica; 2014 Nov; 99(11):e228-30. PubMed ID: 25015939
    [No Abstract]   [Full Text] [Related]  

  • 37. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adolescents and young adults with acute lymphoblastic leukemia. A specific management].
    Boissel N; Ducassou S
    Bull Cancer; 2017; 104(7-8):683-689. PubMed ID: 28576259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Shigematsu A; Kako S; Mitsuhashi K; Iwato K; Uchida N; Kanda Y; Fukuda T; Sawa M; Senoo Y; Ogawa H; Miyamura K; Takada S; Nagamura-Inoue T; Morishima Y; Ichinohe T; Atsuta Y; Mizuta S; Tanaka J
    Int J Hematol; 2017 Jun; 105(6):805-811. PubMed ID: 28197965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
    Stirewalt DL; Guthrie KA; Beppu L; Bryant EM; Doney K; Gooley T; Appelbaum FR; Radich JP
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):206-12. PubMed ID: 12652472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.